{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:26:18Z","timestamp":1792585578706,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.drugalcdep.2016.11.032","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T18:48:20Z","timestamp":1481741300000},"page":"122-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses"],"prefix":"10.1016","volume":"171","author":[{"given":"Zanib","family":"Bi-Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Hearty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0005","first-page":"22","article-title":"Drug treatment practitioners\u2019 perceptions of methadone diversion and their responses to it","volume":"20","author":"Baldwin","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","article-title":"Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0015","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1046\/j.1360-0443.2002.00229.x","article-title":"Drug use and initiation in prison: results from a national prison survey in England and Wales","volume":"97","author":"Boys","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0020","series-title":"Appraisal Tool","author":"Critical Appraisal Skills Programme (CASP)","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0025","series-title":"Drugs in Prison","author":"Centre for Social Justice","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0030","series-title":"Multiple Dose Study of Blockade of Opioid Effects of Subcutaneous Injections of Buprenorphine in Participants With Opioid Use Disorder","author":"ClinicalTrials.gov","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2007.08.008","article-title":"Prescription opioid use, misuse, and diversion among street drug users in New York City","volume":"92","author":"Davis","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence: and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0045","series-title":"Prisons and Drugs: A Global Review of Incarceration, Drug Use and Drug Services","author":"Dolan","year":"2007"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: a systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0055","first-page":"1","article-title":"Buprenorphine snorters: a case series","author":"George","year":"2007","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/bsl.1015","article-title":"Medication\u2010assisted treatment research with criminal justice populations: challenges of implementation","volume":"29","author":"Gordon","year":"2011","journal-title":"Behav. Sci. Law"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Gwin Mitchell","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hendrich","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0075","first-page":"2011","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated march 2011]","author":"Higgins","year":"2011","journal-title":"The Cochrane Collaboration"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugpo.2010.10.004","article-title":"The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia","volume":"22","author":"Horyniak","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2011.12.014","article-title":"Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada","volume":"124","author":"Johnson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease","volume":"37","author":"Kinlock","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAF.0b013e3181e8af3d","article-title":"The methadone epidemic: methadone-related deaths on the rise in Vermont","volume":"32","author":"Madden","year":"2011","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0105","first-page":"25","article-title":"Who completes prison drug treatment","volume":"179","author":"Marriott","year":"2008","journal-title":"Prison Serv. J."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/09595230801956157","article-title":"Incarceration experiences in a cohort of active injection drug users","volume":"27","author":"Milloy","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0115","series-title":"A Survey of Buprenorphine Misuse in Prison","author":"Ministry of Justice","year":"2007"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0120","series-title":"Special Report, US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics","article-title":"Drug use and dependence, state and federal prisoners, 2004","author":"Mumola","year":"2006"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0125","series-title":"Process and Methods Guide. The Guidelines Manual","author":"National Institute of Clinical Excellence","year":"2012"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0130","series-title":"Prescription Drug Abuse. Research Report Series","author":"National Institute on Drug Abuse","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0135","series-title":"National Voluntary Consensus Standards for the Treatment of Substance Use Conditions. Evidenced Based Treatment Practice","author":"National Quality Forum (NQF)","year":"2007"},{"issue":"1","key":"10.1016\/j.drugalcdep.2016.11.032_bib0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1078345813518629","article-title":"Prescribing in prison: minimizing psychotropic drug diversion in correctional practice","author":"Pilkinton","year":"2014","journal-title":"J. Correct. Health Care"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0150","series-title":"Managing Persistent Pain in Secure Settings","article-title":"Faculty of pain medicine of the royal college of anaesthetists","author":"Public Health England","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0155","series-title":"Safer Prescribing in Prisons: Guidance for Clinicians","author":"Royal College of General Practitioners","year":"2011"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0160","series-title":"Handbook on Evidence-Based Substance Abuse Treatment Practice in Criminal Justice Settings","article-title":"Pharmacotherapy","author":"Schwartz","year":"2011"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000279766","article-title":"Bioavailablity of Buprenorphine from crushed and whole Buprenorphine (Buprenorphine) tablets","volume":"16","author":"Simojoki","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/0954026021000046092","article-title":"Substance misuse among prisoners in England and Wales","volume":"15","author":"Singleton","year":"2003","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.008","article-title":"Relative bioavailability of different buprenorphine formulations under chronic dosing conditions","volume":"74","author":"Strain","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1468-2311.00096","article-title":"The effect of the prison environment upon inmate drug taking behaviour","volume":"37","author":"Swann","year":"1998","journal-title":"Howard J. Crim. Justice"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17449200902880482","article-title":"Exploring buprenorphine misuse in prisons: a qualitative study of former prisoners","volume":"5","author":"Tompkins","year":"2009","journal-title":"Int. J. Prison. Health"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2009.03.008","article-title":"Open-label dose-finding trial of buprenorphine implants (Probuphine)\u00ae for treatment of heroin dependence","volume":"103","author":"White","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1108\/09654281211190245","article-title":"Social and environmental factors influencing in-prison drug use","volume":"112","author":"Woodall","year":"2011","journal-title":"Health Educ."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0205","series-title":"Abuse (drug, Alcohol, Chemical, Substance or Psychoactive Substance)","author":"World Health Organisation","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0210","series-title":"The Offender And Drug Treatment: Making It Work Across Prisons And Wider Secure Environments","author":"Wright","year":"2012"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2296-15-64","article-title":"The safe implementation of a prison-based methadone maintenance programme: 7 year time-series analysis of primary care prescribing data","volume":"15","author":"Wright","year":"2014","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.drugalcdep.2014.09.775","article-title":"Comparative prices of diverted buprenorphine\/naloxone and buprenorphine in a UK prison setting: a cross-sectional survey of drug using prisoners","volume":"144","author":"Wright","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1108\/IJPH-09-2014-0032","article-title":"Injecting drug use in prison: prevalence and implications for needle exchange policy","volume":"11","author":"Wright","year":"2015","journal-title":"Int. J. Prison. Health"},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J069v26n04_03","article-title":"Prescription drug abuse among prisoners in rural southwestern Virginia","volume":"26","author":"Wunsch","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2016.11.032_bib0235","series-title":"Assessment of Qualitative Research in Systematic Reviews: CRDs Guidance for Undertaking Reviews in Healthcare","author":"York University Centre for Reviews","year":"2009"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161631047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161631047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:20:56Z","timestamp":1536196856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161631047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":47,"alternative-id":["S037687161631047X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.032","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}